Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 338

1.

Evaluation of a single-scan protocol for radiochromic film dosimetry.

Shimohigashi Y, Araki F, Maruyama M, Nakaguchi Y, Kuwahara S, Nagasue N, Kai Y.

J Appl Clin Med Phys. 2015 Mar 8;16(2):5226. doi: 10.1120/jacmp.v16i2.5226.

2.

Validation of fluence-based 3D IMRT dose reconstruction on a heterogeneous anthropomorphic phantom using Monte Carlo simulation.

Nakaguchi Y, Ono T, Maruyama M, Nagasue N, Shimohigashi Y, Kai Y.

J Appl Clin Med Phys. 2015 Jan 8;16(1):5199. doi: 10.1120/jacmp.v16i1.5199.

3.

Optimization of acquisition parameters and accuracy of target motion trajectory for four-dimensional cone-beam computed tomography with a dynamic thorax phantom.

Shimohigashi Y, Araki F, Maruyama M, Nakaguchi Y, Nakato K, Nagasue N, Kai Y.

Radiol Phys Technol. 2015 Jan;8(1):97-106. doi: 10.1007/s12194-014-0296-8. Epub 2014 Oct 7.

PMID:
25287015
4.

Validation of a quick three-dimensional dose verification system for pre-treatment IMRT QA.

Nakaguchi Y, Araki F, Ono T, Tomiyama Y, Maruyama M, Nagasue N, Shimohigashi Y, Kai Y.

Radiol Phys Technol. 2015 Jan;8(1):73-80. doi: 10.1007/s12194-014-0294-x. Epub 2014 Sep 27.

PMID:
25261343
5.

[Development of a quality assurance phantom for brachytherapy: the feasibility of daily check with the phantom].

Kai Y, Murakami R, Maruyama M, Nakaguchi Y, Nagasue N, Kakei K, Takenaga E, Hashida M, Saito T.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2014 Jan;70(1):34-40. Japanese.

6.

Trends in surgical results of hepatic resection for hepatocellular carcinoma: 1,000 consecutive cases over 20 years in a single institution.

Yamashita Y, Tsuijita E, Takeishi K, Ishida T, Ikegami T, Ezaki T, Maeda T, Utsunomiya T, Nagasue N, Shirabe K, Maehara Y.

Am J Surg. 2014 Jun;207(6):890-6. doi: 10.1016/j.amjsurg.2013.07.028. Epub 2013 Oct 18.

PMID:
24144344
7.

[Comparison of various image guided radiation therapy systems; image-guided localization accuracy and patient throughput].

Takenaga E, Nakaguchi Y, Maruyama M, Nagasue N, Kakei K, Kai Y, Kouno T, Sasaki M, Hashida M.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2012;68(10):1327-32. Japanese.

8.

[Comparison of dose accuracy between 2D array detectors for pre-treatment IMRT QA].

Nakaguchi Y, Araki F, Saiga S, Kouno T, Maruyama M, Kakei K, Nagasue N, Hashida M.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2012;68(4):443-52. Japanese.

9.

[Dosimetric correction for a six degrees carbon fiber couch].

Nakaguchi Y, Murakami R, Maruyama M, Kakei K, Nagasue N, Araki F.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2011;67(12):1592-7. Japanese.

10.

Radiation exposure of operator performing interventional procedures using a flat panel angiography system: evaluation with photoluminescence glass dosimeters.

Funama Y, Nagasue N, Awai K, Sakamoto I, Kakei K, Shimamura M, Yamashita Y, Uetani M.

Jpn J Radiol. 2010 Jul;28(6):423-9. doi: 10.1007/s11604-010-0444-y. Epub 2010 Jul 27.

PMID:
20661692
11.

Body mass index influences long-term outcome in patients with colorectal cancer.

Shibakita M, Yoshimura H, Tachibana M, Ueda S, Nagasue N.

Hepatogastroenterology. 2010 Jan-Feb;57(97):62-9.

PMID:
20422873
12.

[Combinations of scan parameters and image quality at C-arm CT for abdominal imaging].

Nagasue N, Funama Y, Oniki R, Segawa A, Iwatake S, Kawachino T, Uetani M.

Nihon Hoshasen Gijutsu Gakkai Zasshi. 2009 Jun 20;65(6):765-72. Japanese.

13.

A resected case of liver metastasis from colon cancer that occurred 13 years after a colectomy.

Yamaguchi M, Yamanoi A, Igarashi M, Obmori H, Yoshimura H, Tanaka T, Nagasue N.

Hepatogastroenterology. 2008 Nov-Dec;55(88):2221-3.

PMID:
19260509
14.

Blocking intrahepatic inflow and backflow using Chang's needle during hepatic resection: Chang's maneuver.

Chang YC, Nagasue N.

HPB (Oxford). 2008;10(4):244-8. doi: 10.1080/13651820802166971.

15.

Role of peroxisome proliferator-activated receptor-gamma (PPARgamma) during liver regeneration in rats.

Yamamoto Y, Ono T, Dhar DK, Yamanoi A, Tachibana M, Tanaka T, Nagasue N.

J Gastroenterol Hepatol. 2008 Jun;23(6):930-7. doi: 10.1111/j.1440-1746.2008.05370.x.

PMID:
18565023
16.

Differential expression of RUNX genes in human esophageal squamous cell carcinoma: downregulation of RUNX3 worsens patient prognosis.

Tonomoto Y, Tachibana M, Dhar DK, Onoda T, Hata K, Ohnuma H, Tanaka T, Nagasue N.

Oncology. 2007;73(5-6):346-56. doi: 10.1159/000135350. Epub 2008 May 26.

PMID:
18500170
17.

Experimental investigation of the role of endothelin-1 in idiopathic portal hypertension.

Yamaguchi E, Yamanoi A, Ono T, Nagasue N.

J Gastroenterol Hepatol. 2007 Jul;22(7):1134-40.

PMID:
17608860
18.

Our experiences in surgical treatment for hilar cholangiocarcinoma.

Maeno H, Ono T, Yamanoi A, Nagasue N.

Hepatogastroenterology. 2007 Apr-May;54(75):669-73.

PMID:
17591038
19.

Appraisal of a revised lymph node classification system for esophageal squamous cell cancer.

Dhar DK, Hattori S, Tonomoto Y, Shimoda T, Kato H, Tachibana M, Matsuura K, Mitsumoto Y, Little AG, Nagasue N.

Ann Thorac Surg. 2007 Apr;83(4):1265-72.

PMID:
17383324
20.

FR-167653, a selective p38 MAPK inhibitor, exerts salutary effect on liver cirrhosis through downregulation of Runx2.

Hattori S, Dhar DK, Hara N, Tonomoto Y, Onoda T, Ono T, Yamanoi A, Tachibana M, Tsuchiya M, Nagasue N.

Lab Invest. 2007 Jun;87(6):591-601. Epub 2007 Mar 5.

21.

Fractalkine-CX3CR1 axis regulates tumor cell cycle and deteriorates prognosis after radical resection for hepatocellular carcinoma.

Matsubara T, Ono T, Yamanoi A, Tachibana M, Nagasue N.

J Surg Oncol. 2007 Mar 1;95(3):241-9.

PMID:
17323338
22.

Surgical treatment of superficial esophageal cancer.

Tachibana M, Kinugasa S, Shibakita M, Tonomoto Y, Hattori S, Hyakudomi R, Yoshimura H, Dhar DK, Nagasue N.

Langenbecks Arch Surg. 2006 Aug;391(4):304-21. Epub 2006 Jul 8. Review.

PMID:
16830151
23.

Reduction of radiation dose at HRCT of the temporal bone in children.

Funama Y, Awai K, Shimamura M, Kakei K, Nagasue N, Yamashita Y.

Radiat Med. 2005 Dec;23(8):578-83.

PMID:
16555569
24.

Simplified hepatic resections with the use of a Chang's needle.

Chang YC, Nagasue N, Chen CS, Lin XZ.

Ann Surg. 2006 Feb;243(2):169-72.

25.

Radiation dose reduction without degradation of low-contrast detectability at abdominal multisection CT with a low-tube voltage technique: phantom study.

Funama Y, Awai K, Nakayama Y, Kakei K, Nagasue N, Shimamura M, Sato N, Sultana S, Morishita S, Yamashita Y.

Radiology. 2005 Dec;237(3):905-10. Epub 2005 Oct 19.

PMID:
16237139
26.

Expression of trefoil factor family members correlates with patient prognosis and neoangiogenesis.

Dhar DK, Wang TC, Tabara H, Tonomoto Y, Maruyama R, Tachibana M, Kubota H, Nagasue N.

Clin Cancer Res. 2005 Sep 15;11(18):6472-8.

27.

Expression of hypoxia inducible factor-1alpha during liver regeneration induced by partial hepatectomy in rats.

Maeno H, Ono T, Dhar DK, Sato T, Yamanoi A, Nagasue N.

Liver Int. 2005 Oct;25(5):1002-9.

PMID:
16162160
28.
29.

Inherent potential for production of tumor necrosis factor-alpha by human intestinal macrophages.

Nakata K, Inagawa H, Nishizawa T, Honda T, Kohchi C, Tonomoto Y, Yoshimura H, Nagasue N, Natori S, Terada H, Soma G.

Int J Colorectal Dis. 2006 May;21(4):339-47. Epub 2005 Aug 10.

PMID:
16091914
30.

Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.

Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Ohno Y, Suzuki N, Inoue M, Soma G, Nagasue N.

Anticancer Res. 2005 Jan-Feb;25(1B):463-70.

31.

Clinical outcomes of extended esophagectomy with three-field lymph node dissection for esophageal squamous cell carcinoma.

Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Nagasue N.

Am J Surg. 2005 Jan;189(1):98-109.

PMID:
15701501
32.

Metastatic lymph node size and colorectal cancer prognosis.

Dhar DK, Yoshimura H, Kinukawa N, Maruyama R, Tachibana M, Kohno H, Kubota H, Nagasue N.

J Am Coll Surg. 2005 Jan;200(1):20-8.

PMID:
15631916
33.

Prognostic impact of hypoxia-inducible factors 1alpha and 2alpha in colorectal cancer patients: correlation with tumor angiogenesis and cyclooxygenase-2 expression.

Yoshimura H, Dhar DK, Kohno H, Kubota H, Fujii T, Ueda S, Kinugasa S, Tachibana M, Nagasue N.

Clin Cancer Res. 2004 Dec 15;10(24):8554-60.

34.
35.

Postoperative pulmonary complications are associated with worse short- and long-term outcomes after extended esophagectomy.

Kinugasa S, Tachibana M, Yoshimura H, Ueda S, Fujii T, Dhar DK, Nakamoto T, Nagasue N.

J Surg Oncol. 2004 Nov 1;88(2):71-7.

PMID:
15499604
36.

En-bloc esophagectomy for esophageal cancer.

Tachibana M, Kinugasa S, Yoshimura H, Shibakita M, Tonomoto Y, Dhar DK, Tabara H, Nagasue N.

Am J Surg. 2004 Sep;188(3):254-60. Review.

PMID:
15450830
37.

Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma.

Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N.

J Gastroenterol. 2004 Aug;39(8):763-8.

PMID:
15338370
38.

Estrogen receptor-associated expression of keratinocyte growth factor and its possible role in the inhibition of apoptosis in human breast cancer.

Tamaru N, Hishikawa Y, Ejima K, Nagasue N, Inoue S, Muramatsu M, Hayashi T, Koji T.

Lab Invest. 2004 Nov;84(11):1460-71.

39.

Downregulation of KiSS-1 expression is responsible for tumor invasion and worse prognosis in gastric carcinoma.

Dhar DK, Naora H, Kubota H, Maruyama R, Yoshimura H, Tonomoto Y, Tachibana M, Ono T, Otani H, Nagasue N.

Int J Cancer. 2004 Oct 10;111(6):868-72.

40.

Profile of cytokines produced in tumor tissue after administration of cyclophosphamide in a combination therapy with tumor necrosis factor.

Takiguchi K, Nakamoto T, Inagawa H, Kohchi C, Nishizawa T, Nagasue N, Soma G.

Anticancer Res. 2004 May-Jun;24(3a):1823-8.

41.

Doxycycline inhibits cell proliferation and invasive potential: combination therapy with cyclooxygenase-2 inhibitor in human colorectal cancer cells.

Onoda T, Ono T, Dhar DK, Yamanoi A, Fujii T, Nagasue N.

J Lab Clin Med. 2004 Apr;143(4):207-16.

PMID:
15085079
42.

Transforming growth factor-beta1 induced hepatocyte apoptosis--a possible mechanism for growth of colorectal liver metastasis.

Hayashi H, Kohno H, Ono T, Yamanoi A, Dhar DK, Ueda S, Rahman MA, Kubota H, Nagasue N.

Acta Oncol. 2004;43(1):91-7.

PMID:
15068326
43.

Expression of regenerating gene I in gastric adenocarcinomas: correlation with tumor differentiation status and patient survival.

Dhar DK, Udagawa J, Ishihara S, Otani H, Kinoshita Y, Takasawa S, Okamoto H, Kubota H, Fujii T, Tachibana M, Nagasue N.

Cancer. 2004 Mar 15;100(6):1130-6.

44.

The degree of macrophage infiltration into the cancer cell nest is a significant predictor of survival in gastric cancer patients.

Ohno S, Inagawa H, Dhar DK, Fujii T, Ueda S, Tachibana M, Suzuki N, Inoue M, Soma G, Nagasue N.

Anticancer Res. 2003 Nov-Dec;23(6D):5015-22.

PMID:
14981961
45.

Extended esophagectomy with 3-field lymph node dissection for esophageal cancer.

Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Nagasue N.

Arch Surg. 2003 Dec;138(12):1383-9; discussion 1390. Review.

PMID:
14662544
46.

Prognostic significance of metastatic lymph node size in patients with gastric cancer.

Dhar DK, Kubota H, Kinukawa N, Maruyama R, Kyriazanos ID, Ohno S, Nagasue N.

Br J Surg. 2003 Dec;90(12):1522-30.

PMID:
14648731
47.

Transforming growth factor-beta1 released from the spleen exerts a growth inhibitory effect on liver regeneration in rats.

Ueda S, Yamanoi A, Hishikawa Y, Dhar DK, Tachibana M, Nagasue N.

Lab Invest. 2003 Nov;83(11):1595-603.

48.

Evaluation of the antiangiogenic effect of Taxol in a human epithelial ovarian carcinoma cell line.

Hata K, Osaki M, Dhar DK, Nakayama K, Fujiwaki R, Ito H, Nagasue N, Miyazaki K.

Cancer Chemother Pharmacol. 2004 Jan;53(1):68-74. Epub 2003 Oct 21.

PMID:
14569416
49.

Impact of uncoupling protein-2 expression on the prognosis of gastric adenocarcinoma patients.

Kyriazanos ID, Dhar DK, Rahman MA, Ohno S, Kubota H, Kohno H, Nagasue N.

Dig Liver Dis. 2003 Aug;35(8):597-9. No abstract available.

PMID:
14567467
50.

Does fibrin glue reduce lymph leakage (pleural effusion) after extended esophagectomy? Prospective randomized clinical trial.

Tachibana M, Kinugasa S, Yoshimura H, Dhar DK, Ueda S, Fujii T, Kohno H, Nagasue N.

World J Surg. 2003 Jul;27(7):776-81.

PMID:
14509504

Supplemental Content

Loading ...
Support Center